AZN AstraZeneca PLC Stock Quote

AZN [NASD]

Healthcare | Drug Manufacturers - General | United Kingdom

Index	-	P/E	94.38	EPS (ttm)	0.63	Insider Own	0.50%	Shs Outstand	2.99B	Perf Week	3.39%
Market Cap	182.38B	Forward P/E	15.39	EPS next Y	3.89	Insider Trans	0.00%	Shs Float	2.60B	Perf Month	4.82%
Income	1.47B	PEG	4.58	EPS next Q	0.74	Inst Own	17.40%	Short Float	0.24%	Perf Quarter	0.93%
Sales	32.82B	P/S	5.56	EPS this Y	137.20%	Inst Trans	-0.03%	Short Ratio	1.35	Perf Half Y	4.00%
Book/sh	13.28	P/B	4.51	EPS next Y	20.56%	ROA	1.90%	Target Price	67.68	Perf Year	13.83%
Cash/sh	2.35	P/C	25.51	EPS next 5Y	20.60%	ROE	6.90%	52W Range	46.48 - 64.21	Perf YTD	2.73%
Dividend	1.40	P/FCF	134.50	EPS past 5Y	1.70%	ROI	12.20%	52W High	-6.81%	Beta	0.52
Dividend %	2.34%	Quick Ratio	0.70	Sales past 5Y	1.50%	Gross Margin	71.20%	52W Low	28.74%	ATR	0.87
Employees	76100	Current Ratio	1.10	Sales Q/Q	50.00%	Oper. Margin	8.60%	RSI (14)	65.12	Volatility	1.32% 1.33%
Optionable	Yes	Debt/Eq	0.80	EPS Q/Q	-323.80%	Profit Margin	4.50%	Rel Volume	1.29	Prev Close	58.85
Shortable	Yes	LT Debt/Eq	0.73	Earnings	Feb 10 BMO	Payout	217.40%	Avg Volume	4.57M	Price	59.84
Recom	2.00	SMA20	3.63%	SMA50	3.98%	SMA200	4.30%	Volume	5,901,518	Change	1.68%

Dec-07-21

Downgrade

Jefferies

Buy → Hold

Aug-12-21

Resumed

JP Morgan

Overweight

Apr-12-21

Downgrade

Argus

Buy → Hold

Mar-16-21

Upgrade

Jefferies

Hold → Buy

Feb-25-21

Upgrade

UBS

Neutral → Buy

Jan-15-21

Initiated

Deutsche Bank

Buy

Dec-07-20

Upgrade

Morgan Stanley

Equal-Weight → Overweight

Nov-30-20

Upgrade

UBS

Sell → Neutral

Nov-11-20

Upgrade

HSBC Securities

Reduce → Hold

Sep-29-20

Initiated

Berenberg

Buy

Nov-22-19

Initiated

SVB Leerink

Outperform

Oct-25-19

Upgrade

Liberum

Hold → Buy

Apr-02-19

Downgrade

UBS

Neutral → Sell

Feb-05-19

Initiated

Exane BNP Paribas

Outperform

Jan-25-19

Upgrade

Shore Capital

Hold → Buy

Dec-11-18

Resumed

Jefferies

Hold

Oct-09-18

Initiated

Guggenheim

Buy

Aug-16-18

Downgrade

Jefferies

Buy → Hold

Mar-19-18

Upgrade

Jefferies

Hold → Buy

Feb-06-18

Reiterated

Leerink Partners

Mkt Perform

$36 → $38

Jan-18-22 05:50PM	IMFINZI® (durvalumab) Plus Tremelimumab Demonstrated Unprecedented Survival in 1st-line Unresectable Liver Cancer With 31% of Patients Alive at Three Years Business Wire
05:20PM	IMFINZI® (durvalumab) Plus Chemotherapy Reduced Risk of Death by 20% in 1st-Line Advanced Biliary Tract Cancer Business Wire
03:19PM	Omicron: Why a fourth dose of coronavirus vaccines may not be 'absolutely necessary,' doctor says Yahoo Finance Video
10:06AM	AstraZeneca (AZN) Enhertu sBLA Receives FDA Priority Tag Zacks
Jan-17-22 07:41PM	CORRECTING and REPLACING ENHERTU® granted Priority Review in the US for patients with HER2-positive metastatic breast cancer treated with a prior anti-HER2-based regimen Business Wire
07:00AM	This Could Be Another Blockbuster Indication for AstraZeneca Motley Fool
Jan-14-22 02:12PM	AstraZeneca (AZN) COVID-19 Booster Dose Useful Against Omicron Zacks
06:52AM	Citigroup Says 99% of U.S. Staff Comply With Covid Vaccine Mandate Barrons.com
Jan-13-22 07:14AM	AstraZeneca Sells Additional Half-Million Doses Of Its COVID-19 Antibody To US Benzinga
07:08AM	AstraZeneca's COVID-19 Vaccine Booster Against Omicron, Delta - New Data Supports Use Benzinga
07:08AM	Adagio's COVID-19 Antibody Has Neutralizing Activity Comparable To Other Antibodies Benzinga
07:05AM	AstraZeneca Aims to Redefine Liver, Biliary Tract and Prostate Cancer Treatment With Practice-Changing IMFINZI® (durvalumab) and LYNPARZA® (olaparib) Data at ASCO GI and GU Business Wire
07:00AM	TEZSPIRE Now Available in the United States for the Treatment of Severe Asthma Business Wire
05:59AM	Scorpion Therapeutics, AstraZeneca Ink Precision Medicines Pact For Hard-To-Target Cancer Proteins Benzinga
03:07AM	UPDATE 2-AstraZeneca says early trial data indicates third dose helps against Omicron Reuters
Jan-12-22 02:56PM	Novavax CEO: 'We're going to make a significant impact on this COVID pandemic' Yahoo Finance
01:50PM	CORRECTED-UPDATE 1 -AstraZeneca says U.S. to buy additional 500,000 Evusheld doses (Jan. 12) Reuters
01:34PM	CORRECTED-AstraZeneca says U.S. to buy additional 500,000 Evusheld doses (Jan 12) Reuters
11:39AM	Veru (VERU) Up on FDA's Fast Track Tag for Breast Cancer Drug Zacks
06:20AM	Covis Midco 2 S.a r.l. -- Moody's assigns B2 ratings to Covis Pharma; outlook stable Moody's
Jan-11-22 04:33PM	COVID: How insurers may be expected to cover testing costs Yahoo Finance Video
03:33PM	COVID-19: U.S. reports 1.35 million daily cases, CDC mulls recommending KN95 masks Yahoo Finance Video
10:03AM	London stocks ride a global bounce, with retailers and energy names higher MarketWatch
Jan-10-22 04:30PM	Fusion Pharmaceuticals Announces Nomination of First Targeted Alpha Therapy Candidate in Collaboration with AstraZeneca to Advance into IND-Enabling Studies for Phase 1 Development PR Newswire
04:30PM	Fusion Pharmaceuticals Announces Nomination of First Targeted Alpha Therapy Candidate in Collaboration with AstraZeneca to Advance into IND-Enabling Studies for Phase 1 Development CNW Group
03:37PM	COVID-19 and existing care are bringing hospitals to the brink: Emergency medicine physician Yahoo Finance Video
02:52PM	Omicron: 'Vaccines still prevent serious illness, hospitalization, and death' Yahoo Finance Video
11:15AM	AstraZeneca (AZN) Inks Deal to Develop ATTR-CM Candidate Zacks
Jan-08-22 06:40AM	2 Growth Stocks That Are Also Generating Billions in Free Cash Motley Fool
Jan-07-22 04:26PM	How Nomi Health Fills in Gaps in the Health Care Industry Yahoo Finance Video
11:25AM	Africa's struggle to get COVID vaccine doses: 'We feel forgotten' Yahoo Finance
Jan-06-22 04:31PM	COVID-19: 'There's no significant data saying there's a huge amount of transmission in school,' says doctor Yahoo Finance Video
10:59AM	UPDATE 2-Tie pharma CEO pay to fair global COVID-19 vaccine access, investors say Reuters
03:11AM	Tie pharma CEO pay to fair global COVID-19 vaccine access, investors say Reuters
Jan-05-22 04:22PM	COVID-19: Testing at the first time you have symptoms, thats really the most important time to test, says Dr. Payal Patel Yahoo Finance Video
02:03PM	Omicron Biocontainment Unit medical director: Kids should be wearing masks in schools right now, doctor says Yahoo Finance Video
Jan-04-22 04:35PM	COVID-19: Were seeing more kids in emergency departments, says Dr. James Simmons Yahoo Finance Video
02:32PM	U.S. court revives lawsuit against Pfizer, others on Iraq terrorism funding claims Reuters
02:26PM	UPDATE 1-U.S. court revives lawsuit against Pfizer, others on Iraq terrorism funding claims Reuters
12:27PM	Genprex's (GNPX) Lead Cancer Drug Gets Second Fast Track Tag Zacks
11:56AM	Omicron: Theres been a lack of concern for younger children with COVID-19, doctor says Yahoo Finance Video
08:47AM	Gritstone Bio's COVID-19 Booster Dose Shows Early Neutralizing Antibody Responses Benzinga
Jan-03-22 04:52PM	Doctor on CDC adding testing to isolation guidelines: I've agreed virtually 100% with the CDC... this is one I would push back on Yahoo Finance Video
12:25PM	GNPX Stock: 5 Things to Know as Genprex Rockets Higher InvestorPlace
12:05PM	Apellis (APLS) Up More Than 40% in Past 3 Months: Here's Why Zacks
11:39AM	Omicron is particularly dangerous for the unvaccinated, doctor says Yahoo Finance Video
07:25AM	Ovid Therapeutics Expands Its Anti-Epileptic Franchise With AstraZeneca Licensing Pact Benzinga
Jan-01-22 06:55AM	Could AstraZeneca Help You Retire a Millionaire? Motley Fool
Dec-31-21 01:47PM	Omicron: Doctor explains how hospitalizations are still a problem despite apparent lessened severity Yahoo Finance Video
Dec-30-21 06:15PM	Astrazeneca (AZN) Dips More Than Broader Markets: What You Should Know Zacks
10:07AM	AstraZeneca (AZN) Closes Agreement for Eplontersen With Ionis Zacks
09:27AM	U.S. COVID-19 cases skyrocket to pandemic high as Omicron and Delta variants spread Yahoo Finance Video
Dec-29-21 04:56PM	COVID-19: 'Youre going to see increased hospitalizations based on the sheer volume,' says Dr. Rajeev Fernando Yahoo Finance Video
02:00PM	Year in review: Novavax, Emergent stay on a vaccine roller coaster American City Business Journals
11:59AM	Moderna: Our concern is more in valuation with booster shots 'baked into the stock,' analyst says Yahoo Finance Video
11:41AM	Daily U.S. COVID-19 cases hit all-time record, CDC estimates 59% are Omicron Yahoo Finance Video
10:22AM	Novavax (NVAX) COVID Jab Gets Nod for Emergency Use in India Zacks
Dec-28-21 05:08PM	COVID-19: Many feel its somewhat reckless to tell people after 5 days you can assume youre fine and clear says Emergency Medicine Physician Yahoo Finance Video
05:00PM	After 1,200% Rally, Koreas Star Tech Stocks Need Staying Power Bloomberg
07:00AM	More Covid-19 Vaccines Are Reaching Poorer Nations, but Slowly The Wall Street Journal
04:54AM	Novavax Gains as Covid Shot Gets Nod in India Investing.com
Dec-27-21 11:38PM	Advisors' Inner Circle Fund III Buys Petroleo Brasileiro SA Petrobras, Devon Energy Corp, ... GuruFocus.com
11:38PM	Advisors' Inner Circle Fund III Buys Petroleo Brasileiro SA Petrobras, Gazprom PJSC, Roche ... GuruFocus.com
08:38PM	Six Circles Managed Eq Port Intl Unconstrained Fnd Buys AstraZeneca PLC, DNB Bank ASA, DNB Bank ... GuruFocus.com
04:58PM	COVID-19: We dont really know what Omicron is going to do in terms of Long-COVID, doctor says Yahoo Finance Video
Dec-24-21 06:00PM	Astrazeneca (AZN) Stock Sinks As Market Gains: What You Should Know Zacks
11:00AM	AstraZenecas Vaccine, Dumped by the West, Helps Fill Gaping Need in Rest of World The Wall Street Journal
09:13AM	Pharma Stock Roundup: FDA Approves PFE & MRK's Oral Pills for COVID & Other Drugs Zacks
07:38AM	Putnam VT Large Cap Value Fund Buys McKesson Corp, AstraZeneca PLC, Stanley Black & Decker ... GuruFocus.com
Dec-23-21 06:15PM	Astrazeneca (AZN) Stock Sinks As Market Gains: What You Should Know Zacks
05:38PM	Putnam International Equity Fund Buys KDDI Corp, SSE PLC, Roche Holding AG, Sells AIA Group, ... GuruFocus.com
05:00PM	3 COVID Stocks to Fight Omicron Motley Fool
02:38PM	Sit Mutual Funds Inc Buys Truist Financial Corp, Baxter International Inc, The AES Corp, Sells ... GuruFocus.com
12:34PM	Why COVID-19 tests are in short supply and results are delayed Yahoo Finance Video
12:18PM	Oxford Lab Study Suggests AstraZeneca's COVID-19 Booster Works Against Omicron Benzinga
11:30AM	Omicron: 'Relatively good news' based on early data, doctor says Yahoo Finance Video
10:49AM	COVID-19: We need a more rational approach to Omicron, doctor says Yahoo Finance Video
09:30AM	Novavax CEO: FDA filing for COVID-19 vaccine is probably going to be next week Yahoo Finance Video
07:00AM	EVUSHELD long-acting antibody combination retains neutralizing activity against Omicron variant in studies from Oxford and Washington Universities Business Wire
06:47AM	Novavax Says Covid-19 Vaccine Produces Immune Response to Omicron. The Stock Is Rising. Barrons.com
05:15AM	AstraZeneca Is Ready to Rally Again Based on the Chart Pattern TheStreet.com
04:20AM	WRAPUP 8-Vaccines, pills and data offer some Christmas cheer in face of Omicron advance Reuters
03:49AM	Crude Oil Higher; Large Crude Draw and Omicron Optimism Helps Investing.com
02:41AM	AstraZeneca Says Covid-19 Booster Shot Was Effective Against Omicron in Study MarketWatch
02:30AM	UPDATE 2-AstraZeneca vaccine booster works against Omicron, Oxford lab study finds Reuters
Dec-22-21 01:41PM	Pfizer COVID-19 pill: 'It's positive news' but 'this isn't a magic bullet,' doctor explains Yahoo Finance Video
10:44AM	AstraZeneca's (AZN) Ultomiris sBLA Gets FDA Priority Review Zacks
Dec-21-21 04:20PM	UPDATE 2-AstraZeneca, Oxford aim to produce Omicron-targeted vaccine Reuters
01:03PM	Novavax CEO: 'We will be filing within the next few days' with FDA Yahoo Finance
12:22PM	COVID-19: What the Biden administration is doing to address winter surge in cases Yahoo Finance Video
12:10PM	Novavax CEO: We are making an Omicron variant strain vaccine Yahoo Finance Video
Dec-20-21 11:40AM	Cheplapharm Arzneimittel GmbH -- Moody's changes Cheplapharm's outlook to stable; affirms B2 ratings Moody's
10:53AM	Amgen, AstraZeneca's Asthma Drug Tezepelumab Gets FDA Nod Zacks
09:26AM	Omicron Variant Puts COVID-19 Antibody Treatments in Focus Zacks
06:59AM	Is Argenx a Good Biotech Stock to Buy for 2022? Motley Fool
05:19AM	AstraZeneca - Amgen's Tezspire Biologic Scores FDA Approval For Severe Asthma Benzinga
03:52AM	Novavax Surges After Covid Shot Gets EU Regulators Nod Investing.com
Dec-17-21 11:38PM	Goldman Sachs Variable Insurance Trust International Equity Insights Fund Buys Roche Holding ... GuruFocus.com
06:00PM	Astrazeneca (AZN) Dips More Than Broader Markets: What You Should Know Zacks
05:08PM	UPDATE 2-U.S. FDA approves AstraZeneca-Amgen drug for severe asthma Reuters

AstraZeneca PLC discovers, develops, manufactures, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infection, neuroscience, and gastroenterology worldwide. The company's marketed products include Tagrisso, Lynparza, Imfinzi, Enhertu, Koselugo, Lumoxiti, Equidacent, Zoladex, Faslodex, Iressa, Arimidex, Casodex/Cosudex, and others for oncology diseases; Onglyza, Bydureon, Lokelma, Byetta, Qtern, Symlin, and others for cardiovascular, renal, and metabolism diseases; and Symbicort, Pulmicort, Fasenra, Daliresp/Daxas, Duaklir, Tudorza/Eklira, Bevespi, Breztri, Anifrolumab, and others for respiratory and immunology diseases. It also offers other medicines and COVID-19 products, including Synagis, Fluenz Tetra/FluMist Quadrivalent, Seroquel IR/Seroquel XR, Vimovo, Movantik/Moventig, Nexium, Losec/Prilosec, and COVID-19 Vaccine AstraZeneca. The company serves primary care and specialty care physicians through distributors and local representative offices. It has a collaboration agreement with Daiichi Sankyo to develop and commercialize DS-1062 for the treatment of trophoblast cell-surface antigen 2 (TROP2) tumor; AliveCor, Inc. to develop non-invasive potassium monitoring solutions; Massachusetts General Hospital to accelerate digital health solutions; Sanguina on smartphone application study for hemoglobin management in patients with anemia of chronic kidney disease; Alchemab to enhance prostate cancer research; and Proteros biostructures GmbH to discover and develop novel small molecules. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. It has a collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize small molecule medicines for obesity; and Neurimmune AG to develop and commercialize NI006. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience